Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSV A2 Challenge in Healthy Adults
NCT03388645Phase 1Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2018
- Primary completion
- Nov 2019
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
Phase 1, open-label trial of RSV challenge material in respiratory syncytial virus infection (RSV), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Participants With Detectable RSV Shedding in Nasopharyngeal Wash at Day 10. Started Feb 2018; status: completed.
02
Drugs
RSV challenge material
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT03388645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03388645.